| DJGordon 2005-12-21, 12:57 am |
| LOL Thanks, but I doubt this doc's showing off anything. She's a breast
cancer specialist giving a CME lecture to other docs. I'm not an MT in the
traditional sense of transcribing notes and reports. I do the behind the
scenes CME, conferences, NDA, pharmaceutical seminars, etc.
Anyway, thanks, as I had put nabpaclitaxel and now I can change it to NAB
paclitaxel.
Dani
"Nickie" <moretti@cableone.net> wrote in message
news:11qhqqoa24n8253@corp.supernews.com...
> The approval marks a new class of "protein-bound particle" drugs, now made
> possible by ABI's proprietary
> nanoparticle albumin-bound (nabT) technology. Abraxane is the first in
> this new class of drugs.
> (http://www.obgyn.net/bh/bh.asp?page=/news/abraxane_2005)
>
> I love being able to research stuff like this; I'll never forget that
> Abraxane is a nanoparticle albumin-bound drug; thus NAB paclitaxel !!!
> (Doc was probably just being a show-off with the new abbr; probably just
> learned it and has been using the term all day long to stump everyone)....
> Ha ha ha!
>
> Thanks for the challenge
>
>
> "DJGordon" <danigordon@bellsouth.net> wrote in message
> news:6o4qf.20324$k76.2993@bignews6.bellsouth.net...
>
>
|